Johnson & Johnson Innovation – JJDC, Koch Strategic Platforms and Dentsu Ventures are all shareholders in the diagnostic testing technology developer.
Cue Health, a US-based diagnostic testing technology developer backed by marketing firm Dentsu, chemical and energy group Koch Industries and pharmaceutical firm Johnson & Johnson, has filed for an initial public offering.
The company has set a $100m placeholder target for the IPO, which is set to be held on the Nasdaq Global Market.
Cue Health was founded in 2010 and is working on portable diagnostic testing devices for a variety of diseases including covid-19. The company’s devices use…
